Medical/dental staff newsletter [September 1991]

              /£$3_^_   Medical/Dental
wesleylong   Staff Newsletter
COMMUNITY HOSPITAL,
September 1991
Physician News
Edwin Bryan, M.D., has been elected President of the
Wesley Long Medical/Dental Staff, succeeding Dr.
Houston Kimbrough. William Hopper, M.D., was
elected President-Elect and Dr. Stephen Blievernicht,
was elected Secretary.
New Phvsicians/Dentists
Frederick Benedict, M.D. - Orthopedic Surgery
Associates: Maultsby Orthopedic Clinic
Medical School: University of Cincinnati
Internship: Jewish Hospital of Cincinnati
Residency: Indiana University
R. Andrew Collins, M.D. - Orthopedic Surgery
Associates: Greensboro Orthopaedic Center, P.A.
Medical School: Bowman Gray School of Medicine
Internship: N.C. Baptist Hospital
Residency: N.C. Baptist Hospital
Sara Stoneburner, M.D. - Ophthalmology
Associates: Greensboro Ophthalmology Associates
Medical School: Duke University
Internship: Duke University
Residency: Barnes Hospital
New Phvsician/Dentist Extenders
Lisa Puck, O.R.A.
Employed by Maultsby Orthopedic Clinic
Physicians Resigning from
the Medical/Dental Staff
Patrick Gray, M.D. - OB/GYN
Usha Doshi, M.D. - Neonatology
Come to the Wesley Long
Community Hospital
Family Picnic
Saturday, September 28,1991
10:00 a.m. - 6:00 p.m.
Bryan Park Complex
Don't miss the games, great food
and door prizes!
We promise fun for the whole family.
Physicians, we want to see you there!
Call Medical Staff Services at 854-6291
and let us know you're coming.
ORAL HEALTH CARE GUIDELINES FOR
PATIENTS RECEIVING CANCER
CHEMOTHERAPY
Patients receiving cancer chemotherapy have an
increased susceptibility to infection, often from an
oral source. The decrease in the number of white
blood cells and platelets from chemotherapeutic
agents can also lead to oral mucositis, oral
ulceration, increased risk of hemorrhage, and
impaired healing potential. Removing oral sources
of infection before chemotherapy can reduce the
morbidity and mortality from the occurrence of
acute dental disease during periods of
myelosuppression.
The oral epithelium has a relatively high
reproductive rate and is therefore readily effected by
antineoplastic agents. Oral mucositis is therefore
readily effected by antineoplastic agents. Oral
mucositis may be the result of the direct effect of the
chemotherapy, a supervening infection or both.
These infections, even when not fatal, may cause
significant morbidity by complicating therapy
schedules, prolonging hospitalization and generally
decreasing the quality of life.
Increased risk of hemorrhage, usually the result
of thrombocytopenia, and delayed healing resulting
from either the disease itself or from cancer
chemoatherapy, must be taken into consideration
when timing, planning and implementing dental
treatment.
The American Dental Association recommends
that all patients requiring chemotherapy have a
dental consultation prior to the onset of
chemotherapy. The dental exam will include
clinical and radiographic evaluation, with emphasis
on infected or non-restorable teeth, ill-fitting
prostheses, moderate or advanced periodontal
disease, oral mucosal ulcers and paranasal sinus
disease.
Oral sources of baceremia should be eliminated
before the onset of chemotherapy. During
chemotherapy, only the minimal necessary dental
intervention should be provided to control acute
dental problems. After sehmotherapy cycles.
FROM: American Dental Association; Council on
Community Health, Hospital, Institutional and
Medical Affairs, "Patients Receiving Cancer
Chemotherapy", September 1989.